ArticleJournal of visualized experiments : JoVE2026
An In Vitro Assay For LpxC Degradation By The Membrane-Bound Protease FtsH And Adaptor LapB From Escherichia coli.
Article in Journal of visualized experiments : JoVE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This protocol presents a sensitive, quantitative in vitro degradation assay of LpxC using reconstituted AAA+ (ATPase associated with diverse cellular activities) protease FtsH and adaptor LapB in proteoliposomes. AAA+ proteases are ATP-dependent molecular machines that maintain protein homeostasis and regulate diverse cellular processes in the cytoplasm or at cellular membranes. Compared with their cytoplasmic counterparts, membrane-bound AAA+ proteases remain poorly characterized due to technical challenges in reconstituting and measuring their activity in vitro. Here, we use the FtsH-LapB-LpxC system as a model to develop a fluorescence-based degradation assay in proteoliposomes. FtsH and LapB are reconstituted into proteoliposomes to mimic the native membrane environment, and LpxC is covalently labeled with the fluorescent dye Atto488. Degradation is initiated by combining proteoliposomes with labeled LpxC and ATP and terminated by trichloroacetic acid (TCA). A successful assay is defined by a time-dependent increase in fluorescence in the soluble supernatant fraction after TCA precipitation, corresponding to the release of fluorescent peptide fragments generated by LpxC proteolysis. This signal enables direct quantification of initial degradation rates under defined conditions. Compared with traditional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)-based assays, this method provides substantially improved sensitivity and enables quantitative kinetic analysis. Moreover, the proteoliposome system allows systematic investigation of how protein components, such as adaptors and anti-adaptors, as well as lipid composition, influence LpxC degradation. Although developed for the FtsH-LapB-LpxC system, this assay is readily adaptable to other membrane-bound AAA+ proteases and substrates, providing a general platform for studying membrane-associated proteolysis in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.